drugset / Trial / NCT00469053

Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID: 855509)

NCT00469053

Phase 1 Terminated 36 enrolled Grünenthal GmbH
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine whether two different analgesic transdermal patch formulations lead to same plasma levels of active ingredient after multiple dose application.

Timeline

Start
2007-05
Primary completion
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified Other

Indications

No indication recorded.